Last update 18 Feb 2025

Nanjing Tianyinshan Hospital Co., Ltd.

Private Company | Subsidiary Company|
2021|
Jiangsu Sheng, China
|
tysih.com

Overview

Tags

Neoplasms
Respiratory Diseases
Therapeutic vaccine
Monoclonal antibody
mRNA vaccine

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms2
Endocrinology and Metabolic Disease2
Top 5 Drug TypeCount
Therapeutic vaccine1
Monoclonal antibody1
mRNA vaccine1
Top 5 TargetCount
PDL1(Programmed death-ligand 1)1

Related

2
Drugs associated with Nanjing Tianyinshan Hospital Co., Ltd.
Adebrelimab
Target
PDL1
Mechanism
PDL1 inhibitors
Active Org.
Shanghai Shengdi Pharmaceutical Co., Ltd. [+5]
Originator Org.
Jiangsu Hengrui Pharmaceuticals Co., Ltd.Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Active Indication
Extensive stage Small Cell Lung Cancer [+36]
Inactive Indication
Advanced Esophageal Squamous Cell Carcinoma [+1]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
China
First Approval Date28 Feb 2023
HRXG-K-1939
Target-
Mechanism
Immunostimulants
Active Org.
Chinese People's Liberation Army General HospitalChinese People's Liberation Army General Hospital [+3]
Originator Org.
Shanghai Regenelead Therapies Co., Ltd.Startup
Active Indication
Pancreatic Cancer [+4]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Nanjing Tianyinshan Hospital Co., Ltd.
NCT06685653
/ Not yet recruitingEarly Phase 1
An Exploratory Study of Personalized Neoantigen MRNA Vaccine RGL-270 Combined with Adebrelimab in Non-Small Cell Lung Cancer Patients
100 Clinical Results associated with Nanjing Tianyinshan Hospital Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Nanjing Tianyinshan Hospital Co., Ltd.
Login to view more data
100 Deals associated with Nanjing Tianyinshan Hospital Co., Ltd.
Login to view more data
100 Translational Medicine associated with Nanjing Tianyinshan Hospital Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 19 Apr 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Early Phase 1
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Adebrelimab
 ( PDL1 )		Non-Small Cell Lung Cancer
More
Early Phase 1
HRXG-K-1939
Non-Small Cell Lung Cancer
More
Early Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free